Akebia Therapeutics (AKBA) Reports Q3 Net Loss of $59.5M, Cash and Cash Equivalents of $207.2M
Go back to Akebia Therapeutics (AKBA) Reports Q3 Net Loss of $59.5M, Cash and Cash Equivalents of $207.2M| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 0.94 +0.02 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.92 | 52 Week High | $13.20 | |||
| Open | $0.93 | 52 Week Low | $7.00 | |||
| Day High | $0.95 | P/E | N/A | |||
| Day Low | $0.92 | EPS | $0.00 | |||
| Volume | 11,093,313 | |||||
